Acerca de

AditxtScore™ for COVID-19

A comprehensive immune monitoring solution for returning to normalcy with information, data and confidence.

ิBanner panorama background, health care researchers working in science laboratory, medica

AditxtScore™ for COVID-19 in Arkansas

AditxtScore™ for COVID-19 provides meaningful information to help evaluate one’s personal immunity status to COVID-19. Specifically, individuals will obtain answers to the following questions:

Is there evidence of prior exposure to the SARS-CoV-2 virus or vaccine?
Is there evidence that a robust immune response developed?
Is there evidence this immune response can protect against COVID-19?

Understanding the status of an individual’s immune system is key to developing and administering immunotherapies such as AditxtScore™ for COVID-19. We are providing data which provides a personalized comprehensive profile of the immune system. It is intended to be informative for individual immune responses to viruses, bacterial antigens, peptides, drugs, bone marrow, solid organ transplants, and cancer.

It has broad applicability to many other agents of clinical interest impacting the immune system, including those not yet identified such as future infectious agents.

AditxtScore™ for COVID-19 is being designed to allow individuals to understand, manage and monitor their immune profiles in order to be informed about attacks on or by their immune system. We believe AditxtScore™ for COVID-19 can also assist the medical community in anticipating possible immune responses and reactions to viruses, bacteria, allergens and transplanted organs. It can be useful in anticipating attacks on the body by having the ability to determine its potential response and for developing a plan to deal with an undesirable reaction by the immune system.

The AditxtScore™ for COVID-19 ADVANTAGE

AditxtScore™ for COVID-19 offers a significant view of the immune system in a single test, rather than the current method of relying on multiple tests that lack insights into long-term immunity. The platform can also identify cellular responses, including determination of T cell activation, cytokine production, and B cell receptors (indicative of memory cells). This differentiation provides a unique opportunity to determine long-lasting immunity following natural infection or vaccination.

AditxtScore™ for COVID-19 may also help other companies track the effectiveness of vaccine protocols by monitoring the patient’s immune response. The platform measures levels of multiple Ig isotypes against multiple viral antigens. The increased sensitivity and specificity of the assay lends itself to more accurate assessment of antibody levels and their change over time.